Collaborations

Deal signed for tuberculosis vaccine collaboration

Published in Vaccine Weekly, January 18th, 2006

Ace BioSciences A/S, an infectious diseases company, and the Aeras Global TB Vaccine Foundation of Bethesda, Maryland, have entered a collaboration whereby Ace BioSciences will support characterization of second-generation BCG-based tuberculosis (TB) vaccines under development by Aeras.

The current TB vaccine, BCG, does not provide good protection against pulmonary TB in adults or children. Aeras is working on a range of second-generation BCG vaccines with the aim of enhancing the protection they afford and introducing other improvements such as patient-friendly delivery options. As part of this program, Aeras has developed second-generation recombinant BCG strains...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-01-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry